OraSure Technologies (NASDAQ:OSUR) Shares Gap Down to $7.53

OraSure Technologies, Inc. (NASDAQ:OSURGet Free Report) gapped down before the market opened on Thursday . The stock had previously closed at $7.53, but opened at $7.07. OraSure Technologies shares last traded at $7.07, with a volume of 18,032 shares trading hands.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on OSUR shares. StockNews.com lowered OraSure Technologies from a “buy” rating to a “hold” rating in a research report on Wednesday, November 8th. TheStreet raised OraSure Technologies from a “d+” rating to a “c” rating in a research report on Wednesday, November 8th. Citigroup upped their price objective on OraSure Technologies from $7.00 to $9.00 and gave the stock a “buy” rating in a research report on Monday, December 11th. Finally, JPMorgan Chase & Co. cut their price objective on OraSure Technologies from $6.00 to $5.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 8th.

Read Our Latest Analysis on OSUR

OraSure Technologies Stock Down 0.4 %

The business has a 50-day moving average price of $7.75 and a two-hundred day moving average price of $6.60. The firm has a market cap of $528.32 million, a PE ratio of 10.89 and a beta of 0.16.

OraSure Technologies (NASDAQ:OSURGet Free Report) last issued its earnings results on Tuesday, November 7th. The medical instruments supplier reported $0.27 EPS for the quarter, topping analysts’ consensus estimates of $0.07 by $0.20. The firm had revenue of $89.18 million during the quarter, compared to the consensus estimate of $74.56 million. OraSure Technologies had a net margin of 10.86% and a return on equity of 14.88%. The company’s revenue was down 23.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.07 earnings per share. On average, equities research analysts predict that OraSure Technologies, Inc. will post 0.86 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, insider Kathleen Gallagher Weber sold 24,129 shares of the business’s stock in a transaction on Tuesday, December 19th. The shares were sold at an average price of $8.05, for a total transaction of $194,238.45. Following the completion of the transaction, the insider now owns 254,700 shares in the company, valued at $2,050,335. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 3.80% of the company’s stock.

Hedge Funds Weigh In On OraSure Technologies

Several large investors have recently bought and sold shares of OSUR. Renaissance Technologies LLC boosted its stake in OraSure Technologies by 164.0% in the second quarter. Renaissance Technologies LLC now owns 2,408,519 shares of the medical instruments supplier’s stock valued at $6,527,000 after acquiring an additional 1,496,116 shares in the last quarter. Pacer Advisors Inc. boosted its stake in OraSure Technologies by 122.5% in the fourth quarter. Pacer Advisors Inc. now owns 2,403,333 shares of the medical instruments supplier’s stock valued at $19,707,000 after acquiring an additional 1,323,197 shares in the last quarter. Cannell Capital LLC boosted its stake in OraSure Technologies by 161.0% in the second quarter. Cannell Capital LLC now owns 2,066,690 shares of the medical instruments supplier’s stock valued at $10,354,000 after acquiring an additional 1,274,773 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in OraSure Technologies by 23.6% in the first quarter. Dimensional Fund Advisors LP now owns 2,760,694 shares of the medical instruments supplier’s stock valued at $16,701,000 after acquiring an additional 527,912 shares in the last quarter. Finally, AQR Capital Management LLC boosted its stake in OraSure Technologies by 118.0% in the third quarter. AQR Capital Management LLC now owns 935,510 shares of the medical instruments supplier’s stock valued at $5,548,000 after acquiring an additional 506,312 shares in the last quarter. Institutional investors and hedge funds own 88.76% of the company’s stock.

OraSure Technologies Company Profile

(Get Free Report)

OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions.

Further Reading

Receive News & Ratings for OraSure Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies and related companies with MarketBeat.com's FREE daily email newsletter.